This inventor holds 1 USPTO granted patent. Top assignee: Nantcell, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Wendy M. Higashide and Peptide Therapeutics Against SARS-CoV-2
Introduction
Wendy M. Higashide is an inventor associated with Rosemead, California. Her listed patent work concerns peptide therapeutics targeting the SARS-CoV-2 spike protein.
Latest Patents
Higashide is credited with 1 patent: “Peptide Therapeutics Against SARS-COV-2 Spike Protein.” The invention focuses on peptide-based approaches directed at the viral spike protein.
Career Highlights
Higashide’s listed patent reflects work in biotechnology and therapeutic research related to SARS-CoV-2. She is associated with NantCell, Inc.
Collaborations
Her listed coworkers include Jay Gardner Nelson and Oleksandr Buzko. Their names appear alongside Higashide in connection with the patent work.
Conclusion
Wendy M. Higashide’s recorded invention centers on peptide therapeutics targeting the SARS-CoV-2 spike protein, highlighting her contribution to patent activity in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile